KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Change in Account Payables (2021 - 2025)

LifeMD (LFMD) has disclosed Change in Account Payables for 5 consecutive years, with -$300768.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Account Payables rose 50.41% year-over-year to -$300768.0, compared with a TTM value of $3.2 million through Dec 2025, down 22.31%, and an annual FY2025 reading of $3.2 million, down 22.31% over the prior year.
  • Change in Account Payables was -$300768.0 for Q4 2025 at LifeMD, up from -$4.7 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $8.6 million in Q2 2025 and bottomed at -$4.7 million in Q3 2025.
  • Average Change in Account Payables over 5 years is $447307.2, with a median of $124633.0 recorded in 2021.
  • The sharpest move saw Change in Account Payables soared 1887.81% in 2022, then plummeted 680.84% in 2025.
  • Year by year, Change in Account Payables stood at -$2.4 million in 2021, then surged by 76.07% to -$576066.0 in 2022, then soared by 351.27% to $1.4 million in 2023, then tumbled by 141.9% to -$606501.0 in 2024, then skyrocketed by 50.41% to -$300768.0 in 2025.
  • Business Quant data shows Change in Account Payables for LFMD at -$300768.0 in Q4 2025, -$4.7 million in Q3 2025, and $8.6 million in Q2 2025.